Lipoprotein lipase gene polymorphism and lipid profile in coronary artery disease

Loading...
Thumbnail Image

Date

2004

Authors

Duman, Belgin Süsleyici
Türkoğlu, Caner
Akpinar, Belhhan
Güden, Mustafa
Vertii, Alexey
Dak, Esranur
Çağatay, Tülin
Günay, Demet
Buyukdevrim, Ahmet Sevim

Journal Title

Journal ISSN

Volume Title

Publisher

COLL AMER PATHOLOGISTS

Open Access Color

OpenAIRE Downloads

OpenAIRE Views

Research Projects

Organizational Units

Journal Issue

Abstract

Context.-Lipoprotein lipase (LPL) plays a central role in lipid metabolism hydrolyzing triglyceride in chylomicrons and very-low-density lipoproteins. The PvuII polymorphic variant of LPL gene is common and might affect risk of coronary artery disease (CAD). Objective.-Our aim was to determine whether LPL-PvuII polymorphism can be considered to be an independent risk factor or a predictor for CAD in Turkish subjects. Design.-We used polymerase chain reaction and restriction enzyme digestion to determine the distribution of the previously described C-->T transition that causes a PvuII polymorphism in intron 6 among healthy blood donors of Turkish origin and among angiographically confirmed CAD patients with comparable ethnic backgrounds. Results.-For the PvuII genotypes within the CAD group (n = 80) the +/- genotype was found in 39 individuals (48.8%) whereas 25 (31.3%) carried the +/+ genotype and 14 (17.5%) carried the -/- genotype. Within the control group (n = 49) the -/- genotype was found in 19 individuals (38.8%) 16 (32.7%) carried the +/- genotype and 14 (28.6%) carried the +/+ genotype. The genotype frequency distribution was significantly different (P = .049) in the CAD and control study groups. The most frequent genotype among CAD patients was +/-
this genotype was more frequent in patients than in control subjects. However the -/- genotype was more prevalent in the control group. Lipoprotein lipase-PvuII polymorphism was found to be associated with fasting total cholesterol and low-density lipoprotein cholesterol levels. The +/+ genotype was found to have higher levels of total cholesterol and low-density lipoprotein cholesterol in both the CAD and control groups. Conclusion.-There was a difference in the distribution of LPL-PvuII genotypes between the healthy subjects and the patients with CAD. Lipoprotein lipase-PvuII polymorphisms were not detected as independent risk factors for CAD in this study group but had associations with lipid levels.

Description

Keywords

Turkish CoHE Thesis Center URL

Fields of Science

Citation

9

WoS Q

Q1

Scopus Q

Q1

Source

Volume

128

Issue

8

Start Page

869

End Page

874